The phase 4 VESTIGE trial is using functional respiratory imaging to assess the effect of dupilumab on lung function and airway volume in asthma. The following article features coverage from the ...
LOS ANGELES, March 11, 2020 /PRNewswire/ -- The US Food and Drug Administration provided market clearance to Fluidda for its Broncholab platform. Broncholab provides a number of Functional Respiratory ...
FLUIDDA develops proprietary Functional Respiratory Imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the ...
—Abstracts Include the Phase 3 PALM-PAH Study Design, a Presentation of the Previously Disclosed Topline Phase 2b PAH Data, a Functional Respiratory Imaging Analysis from the Phase 2b Study in ...
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), today announced ...
LOS ANGELES, March 11, 2020 /CNW/ -- The US Food and Drug Administration provided market clearance to Fluidda for its Broncholab platform. Broncholab provides a number of Functional Respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results